Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials

Eli Lilly VP Robert Brown is making the jump to serve as CEO of the skin disease-focused Brickell Biotech, as it prepares to move its lead candidate into phase 3 trials for excessive underarm sweating next year.